January 15, 2026 - 03:40

David Webb, a prominent activist investor in Hong Kong, has left an indelible mark on the city’s financial landscape through his relentless pursuit of corporate transparency and accountability. His journey began with the infamous ‘Project Vampire,’ where he exposed the shady dealings and questionable practices of several companies, prompting significant reforms in corporate governance. Webb's advocacy for shareholder rights and ethical business practices has made him a respected figure among investors and a thorn in the side of corporate malfeasance.
As the founder of the ‘Enigma Network,’ Webb continues to champion the cause of transparency in Hong Kong’s markets. This initiative has become a platform for investors to share insights and strategies while advocating for reform in the region’s regulatory framework. His efforts have not only influenced policy changes but have also inspired a new generation of activists and investors to stand up against corporate greed. Webb's legacy is one of empowerment, accountability, and a steadfast commitment to improving the integrity of Hong Kong's financial system.
May 30, 2026 - 02:29
Piper Sandler Reaffirms Overweight on Corebridge Financial (CRBG) Despite Lower Price TargetPiper Sandler has reaffirmed its Overweight rating on Corebridge Financial (CRBG) even as it lowered the price target for the stock. The firm reduced its target to $31 from $35, citing recent stock...
May 29, 2026 - 19:46
AHF Reveals Top 50 Developers and Owners in Latest IssueThe latest issue of Affordable Housing Finance has released its annual ranking of the top 50 developers and owners in the affordable housing sector. The list highlights the companies that have...
May 29, 2026 - 04:11
Americans Are Falling Behind on Their $1.25 Trillion Credit-Card BillSoaring interest rates and stubborn inflation have pushed credit card delinquencies to their highest level since the financial crisis of 2008. According to recent data, the total balance Americans...
May 28, 2026 - 17:58
OSE Immunotherapeutics to Implement a Flexible Bridge Equity FinancingFrench biotech firm OSE Immunotherapeutics has announced a flexible bridge equity financing arrangement, marking the first step in a broader global financing strategy. The company is currently...